tiprankstipranks
Dermapharm Holding SE (DE:DMP)
XETRA:DMP
Germany Market
DMP
Dermapharm Holding SE
RESEARCH TOOLSreports

Dermapharm Holding SE (DMP) Income Statement

12 Followers

Dermapharm Holding SE Income Statement

Last quarter (Q4 2025), Dermapharm Holding SE's total revenue was €295.53M, an increase of 1.67% from the same quarter last year. In Q4, Dermapharm Holding SE's net income was €36.89M. See Dermapharm Holding SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
€ 1.16B€ 1.18B€ 1.14B€ 1.02B€ 942.91M
Gross Profit
€ 391.71M€ 767.07M€ 719.16M€ 660.83M€ 620.69M
Operating Expenses
€ 169.96M€ 550.14M€ 536.27M€ 418.78M€ 333.65M
Depreciation and Amortization
€ 92.56M€ 90.50M€ 104.59M€ 101.18M€ 55.60M
EBITDA
€ 314.31M€ 320.91M€ 265.55M€ 329.81M€ 358.10M
Operating Income
€ 221.75M€ 216.93M€ 182.89M€ 243.69M€ 298.47M
Other Income/Expenses
€ -38.24M€ -44.93M€ -76.90M€ -27.39M€ -5.49M
Pretax Income
€ 183.51M€ 172.00M€ 106.00M€ 216.30M€ 292.98M
Net Income
€ 132.41M€ 113.79M€ 62.37M€ 134.24M€ 209.58M
Per Share Metrics
Basic EPS
€ 2.46€ 2.11€ 1.16€ 2.49€ 3.89
Diluted EPS
€ 2.46€ 2.11€ 1.16€ 2.49€ 3.89
Weighted Average Shares Outstanding
 53.84M 53.84M 53.84M 53.84M 53.84M
Weighted Average Shares Outstanding (Diluted)
 53.84M 53.84M 53.84M 53.84M 53.84M
Currency in EUR

Dermapharm Holding SE Earnings and Revenue History